Open Access
Med Buccale Chir Buccale
Volume 22, Number 2, avril 2016
Page(s) 113 - 117
Section Cas clinique et revue de la littérature / Up-to date review and case report
Published online 10 February 2016
  1. Whitaker J, Landing BH, Esselborn VM, Williams RR. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Clin Endocrinol Metab 1956;16:1374-1387. [CrossRef] [PubMed] [Google Scholar]
  2. Proust-Lemoine E, Wémeau J-L. Syndrome Apeced ou polyendocrinopathie auto-immune de type 1. Presse Médicale 2008;37: 1158-1171. [CrossRef] [Google Scholar]
  3. Proust-Lemoine E, Saugier-Veber P, Wémeau J-L. Polyglandular Autoimmune Syndrome Type I. Presse Médicale 2012;41:e651-662. [CrossRef] [Google Scholar]
  4. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-1836. [CrossRef] [PubMed] [Google Scholar]
  5. Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine A. Dermatological manifestations of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome. Br J Dermatol 2006;154:1088-1093. [CrossRef] [PubMed] [Google Scholar]
  6. Pavlič A, Waltimo-Sirén J. Clinical and microstructural aberrations of enamel of deciduous and permanent teeth in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Arch Oral Biol 2009;54:424-431. [CrossRef] [PubMed] [Google Scholar]
  7. Perheentupa J. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. J Clin Endocrinol Metab 2006;91:2843-2850. [CrossRef] [PubMed] [Google Scholar]
  8. Gibson TJ, Ramu C, Gemünd C, Aasland R. The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor. Trends Biochem Sci 1998;23:242-244. [CrossRef] [PubMed] [Google Scholar]
  9. Lovewell TRJ, McDonagh AJ, Messenger AG, Azzouz M, Tazi-Ahnini R. The AIRE -230Y Polymorphism Affects AIRE Transcriptional Activity: Potential Influence on AIRE Function in the Thymus. PloS One 2015;10:e0127476. [CrossRef] [PubMed] [Google Scholar]
  10. Puissant B. Fonction thymique et auto-immunité. Rev Médecine Interne 2004;25:562-572. [CrossRef] [Google Scholar]
  11. Hayashi A, Shiono H, Okumura M. Thymoma accompanied by lichen planus. Interact Cardiovasc Thorac Surg 2008;7:347-348. [CrossRef] [PubMed] [Google Scholar]
  12. Miyagaki T, Sugaya M, Miyamoto A, Nagata M, Ichimura Y, Mitsui H. Oral erosive lichen planus associated with thymoma treated with etretinate. Australas J Dermatol 2013;54:e25-27. [CrossRef] [PubMed] [Google Scholar]
  13. Kisand K, Bøe Wolff AS, Podkrajšek KT, Tserel L, Link M, Kisand KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010;207:299-308. [CrossRef] [PubMed] [Google Scholar]
  14. Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, et al. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol 2008;154:406-414. [CrossRef] [PubMed] [Google Scholar]
  15. Sitheeque MAM, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003;14:253-267. [CrossRef] [PubMed] [Google Scholar]
  16. Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma – A complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol 2007;43: 607-613. [CrossRef] [PubMed] [Google Scholar]
  17. Böckle BC, Wilhelm M, Müller H, Götsch C, Sepp NT. Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Am Acad Dermatol 2010;62:864-868. [CrossRef] [PubMed] [Google Scholar]
  18. Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. Diagn Microbiol Infect Dis 2008;62:182-185. [CrossRef] [Google Scholar]
  19. Davido M, Stefano F, Lucio LR, Elvira R, Lorenzo LM. Polyglandular autoimmune syndrome type II associated with oral lichen planus. Int J Dermatol 2002;41:244-246. [CrossRef] [PubMed] [Google Scholar]
  20. Maehara T, Moriyama M, Kawano S, Hayashida J-N, Furukawa S, Ohta M, et al. Cytokine profiles contribute to understanding the pathogenic difference between good syndrome and oral lichen planus: two case reports and literature review. Medicine (Baltimore) 2015;94:e704. [CrossRef] [PubMed] [Google Scholar]
  21. Schlosser BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther 2010;23:251-267. [CrossRef] [PubMed] [Google Scholar]
  22. Kamath VV, Setlur K, Yerlagudda K. Oral Lichenoid Lesions - A Review and Update. Indian J Dermatol 2015;60:102. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.